Cushing´s Disease Epidemiology in Sweden

计划入组 502 人 · 首次发布于 2015 年 1 月 29 日

Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease

计划入组 13 人 · 首次发布于 2018 年 12 月 13 日

Long-Term Follow-Up of Survivors of Pediatric Cushing Disease

计划入组 600 人 · 首次发布于 2019 年 2 月 6 日

Scorpion (centruroides) immune Fab2 antivenin (equine)(Anascorp)

Equine collagen

Rabies immune globulin, equine

Rare Disease Research, LLC

CASTLEMAN DISEASE COLLABORATIVE NETWORK

United States

CURE RARE DISEASE, INC.

United States

FDA Approves First Generic Pergolide Tablets for Equine Cushing Disease Treatment

FDA Approves Osilodrostat for Second-Line Cushing Syndrome Treatment as Pipeline Advances

Clofutriben Granted FDA Orphan Drug Designation for Endogenous Cushing Syndrome